Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Clinical & Experimental OncologyISSN: 2324-9110
Joerg Herrmann Author
Subjects of specialization
Affiliation
Anthracycline, Cardiotoxicity, Lymphoma
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
Biography
Joerg Herrmann was working in the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. He has more than 50 publications. His research area realated to Anthracycline. He has more than 40 publications. His current research area related to osteoarthropathy. He is specialised in Anthracycline; Cardiotoxicity; LVEF; Lymphoma; Speckle-tracking echocardiography, 2D; Strain.
Publications
Research Article Open Access
Early Changes in 2D-Speckle-Tracking Echocardiography May Predict a Decrease in Left Ventricular Ejection Fraction in Lymphoma Patients Undergoing Anthracycline Chemotherapy: A Pilot Study
Author(s): Yali Xu, Joerg Herrmann, Patricia A Pellikka, Stephen M. Ansell,Stephen S Cha and Hector R Villarraga
Background: Two-dimensional speckle-tracking echocardiography (2D-STE) may detect early changes in cardiac mechanics in patients with normal left ventricular ejection fraction (LVEF). We aimed to evaluate whether changes in strain or strain rate, as measured by 2D-STE, precede a decrease in LVEF in patients with lymphoma undergoing anthracycline-based chemotherapy (AC).
Methods: We studied patients with lymphoma who und... view more»
Google Scholars / Researchers Sites
